Browse > Article
http://dx.doi.org/10.3904/kjim.2014.29.3.388

Unsupported conclusions in the article "Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female"  

Stohs, Sidney J. (School of Pharmacy and Health Professions, Creighton University Medical Center)
Publication Information
The Korean journal of internal medicine / v.29, no.3, 2014 , pp. 388-392 More about this Journal
Keywords
p-Synephrine; Bitter orange; Citrus aurantium;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Kaats GR, Miller H, Preuss HG, Stohs SJ. A 60day double- blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract. Food Chem Toxicol 2013;55:358-362.   DOI
2 Shara M, Stohs SJ. Safety evaluation of bitter orange extract (p-synephrine) in healthy volunteers. Presented at the 52nd annual meeting of the American College of Nutrition. Abstract No. 16. J Am Coll Nutr 2011;30:358.
3 Dragull K, Breksa AP 3rd, Cain B. Synephrine content of juice from Satsuma mandarins (Citrus unshiu Marcovitch). J Agric Food Chem 2008;56:8874-8878.   DOI
4 Chung H, Kwon SW, Kim TH, et al. Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female. Korean J Intern Med 2013;28:356-360.   DOI   ScienceOn
5 Stohs SJ. Assessment of the adverse event reports associated with Citrus aurantium (bitter orange) from April 2004 to October 2009. J Funct Foods 2010;2:235-238.   DOI   ScienceOn
6 Stohs SJ, Preuss HG, Shara M. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine. Phytother Res 2011;25:1421-1428.   DOI   ScienceOn
7 Stohs SJ, Preuss HG, Shara M. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Int J Med Sci 2012;9:527-538.   DOI
8 Karch SB. Peer review and the process of publishing of adverse drug event reports. J Forensic Leg Med 2007;14:79-84.   DOI   ScienceOn
9 Lynch B. Review of the safety of p-synephrine and caffeine. Intertek-Cantox Report. Mississauga: Intertek Cantox, 2013.
10 Marles R. Synephrine, octopamine and caffeine health risk assessment (HRA) report. Health Canada Natural Health Products Directorate, File No. 172091 [Internet]. Ottawa: Natural Health Products Directorate, 2011 [cited 2014 Feb 2]. Available from: http://www.nutratechinc.com/ advz/Studies2011/Safety/S1%20Health%20Canada%20 0511.pdf.
11 Stohs SJ, Preuss HG, Shara M. A review of the receptor- binding properties of p-synephrine as related to its pharmacological effects. Oxid Med Cell Longev 2011;2011:482973.
12 Uckoo RM, Jayaprakasha GK, Nelson SD, Patil BS. Rapid simultaneous determination of amines and organic acids in citrus using high-performance liquid chromatography. Talanta 2011;83:948-954.   DOI